# Safety, Tolerability and Performance of the NucleoCapture Extracorporeal Therapeutic Apheresis Device in the Reduction of Circulating cfDNA/NETs in Subjects With Pancreatitis

> **NCT06566638** · NA · NOT_YET_RECRUITING · sponsor: **Liverpool University Hospitals NHS Foundation Trust** · enrollment: 20 (estimated)

## Conditions studied

- Acute Pancreatitis
- Organ Failure, Multiple

## Interventions

- **DEVICE:** NucleoCapture device

## Key facts

- **NCT ID:** NCT06566638
- **Lead sponsor:** Liverpool University Hospitals NHS Foundation Trust
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12-01
- **Primary completion:** 2026-12-05
- **Final completion:** 2027-04-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-03-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06566638

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06566638, "Safety, Tolerability and Performance of the NucleoCapture Extracorporeal Therapeutic Apheresis Device in the Reduction of Circulating cfDNA/NETs in Subjects With Pancreatitis". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT06566638. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*